Ixabepilone: In Locally Advanced or Metastatic Breast Cancer

By Moen Marit D.  

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1471-1481

Adis International

Access to resources Recommend Favorite

Ixabepilone delivers in ER− and HER2+ breast cancer

By  

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer

By Denduluri Neelima   Lee James   Walshe Janice   Berman Arlene   Vatas Ujala   Chow Catherine   Steinberg Seth   Cox Michael   Low Jennifer   Swain Sandra  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 63-67

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Safety of Intravenous Ibandronic Acid for Up to 4 Years in Metastatic Breast Cancer: An Open-Label Trial

By Pecherstorfer Martin  

Clinical Drug Investigation, Vol. 26, Iss. 6, 2006-01 ,pp. : 315-322

Adis International

Access to resources Recommend Favorite

Vinorelbine + mitomycin for metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite